Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer

Show full item record



Permalink

http://hdl.handle.net/10138/314730

Citation

Holma , R , Laatikainen , R , Orell , H , Joensuu , H , Peuhkuri , K , Poussa , T , Korpela , R & Österlund , P 2020 , ' Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer ' , Nutrients , vol. 12 , no. 2 , 407 . https://doi.org/10.3390/nu12020407

Title: Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
Author: Holma, Reetta; Laatikainen, Reijo; Orell, Helena; Joensuu, Heikki; Peuhkuri, Katri; Poussa, Tuija; Korpela, Riitta; Österlund, Pia
Contributor: University of Helsinki, Department of Pharmacology
University of Helsinki, Faculty of Medicine
University of Helsinki, Clinicum
University of Helsinki, Heikki Joensuu / Principal Investigator
University of Helsinki, Riitta Anneli Korpela / Principal Investigator
University of Helsinki, HUS Comprehensive Cancer Center
Date: 2020-02
Language: eng
Number of pages: 13
Belongs to series: Nutrients
ISSN: 2072-6643
URI: http://hdl.handle.net/10138/314730
Abstract: Chemotherapy-induced mucosal injury of the small intestine may interfere with the enzymes and transporters responsible for the hydrolysis and absorption of dietary carbohydrates causing diarrhoea, abdominal discomfort and pain. The aim of this study was to investigate the association between the consumption of foods rich in FODMAPs (fermentable oligo-, di- and monosaccharides and polyols) and gastrointestinal symptoms in patients receiving adjuvant therapy for colorectal cancer. The patients (n = 52) filled in a 4-day food diary at baseline and during therapy and kept a symptom diary. The intakes of FODMAP-rich foods were calculated as portions and the intakes were divided into two consumption categories. Patients with high consumption of FODMAP-rich foods had diarrhoea more frequently than those with low consumption (for lactose-rich foods the odds ratio (OR) was 2.63, P = 0.03; and for other FODMAP-rich foods 1.82, P = 0.20). Patients with high consumption of both lactose-rich and other FODMAP-rich foods had an over 4-fold risk of developing diarrhoea as compared to those with low consumption of both (OR, 4.18; P = 0.02). These results were confirmed in multivariate models. Conclusion: Consumption of lactose-rich foods results in an increased risk of diarrhoea during adjuvant therapy for colorectal cancer, especially when the consumption of other FODMAP-rich foods is also high.
Subject: chemotherapy
colorectal cancer
diarrhoea
5-fluorouracil
FODMAP
gastrointestinal symptoms
hypolactasia
lactose intolerance
GASTROINTESTINAL TOXICITY
CONTROLLED-TRIAL
MANAGEMENT
COMPLICATIONS
MECHANISMS
HEALTH
3143 Nutrition
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
nutrients_12_00407.pdf 406.4Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record